Annovis Bio Inc. (ANVS) Prices 1.25M Share Offering at $6/sh

Annovis Bio, Inc. (NYSE: ANVS) today announced the pricing of an underwritten public offering of 1,250,000 units consisting of (i) one share of its common stock and (ii) an accompanying warrant (each warrant to purchase one share of common stock). The combined offering price to the public of each share of common stock and accompanying warrant is $6.00.

All of the shares of common stock and the accompanying warrant are being offered by Annovis. The shares of common stock and the accompanying warrant will be issued separately but can only be purchased together in the offering.

Before deducting the underwriting discounts and commissions and other offering expenses, Annovis expects to receive total gross proceeds of approximately $7.5 million. The offering is expected to close on or about November 2, 2023, subject to the satisfaction of customary closing conditions.

You May Also Be Interested In

• Zenas BioPharma (ZBIO) files for up to 7M share offering by selling stockholders
• Lithium Americas VP of corporate development to retire in September
• Target Hospitality closes secondary offering of 16.1M shares at $18.50